Tezspire approved in Japan for the treatment of severe asthm

Tezspire approved in Japan for the treatment of severe asthma

Tezspire approved in Japan for the treatment of severe asthma

astrazeneca.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from astrazeneca.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , Tokyo , Cambridge , Cambridgeshire , United Kingdom , United States , Japanese , America , Lymphopoietin Isoforms , Astrazeneca Tezspire , Hironori Sagara , Amgen , Nasdaq , World Allergy Organization , Company On Twitter Astrazeneca , Astrazeneca , Showa University School Of Medicine , Investor Relations Team , Japanese Ministry Of Health , Global Asthma Network , Airways Of Human Asthmatics In Vivo , Japanese Ministry , Medicine Division , Respiratory Medicine , Showa University School , Executive Vice President , Asthmain June , New England Journal , Therapy Designation , Priority Review , Orphan Drug Designation , Rare Diseases , Stromal Lymphopoietin Isoforms , Inflammatory Disorders , Human Asthmatics In Vivo , Potential Biomarker , Severe Refractory , Global Asthma , Global Asthma Report , Possible Explanation , Explor Res Hypothesis , Allergy Asthma , Illness Among Patients , Severe Asthma , Managed Care , Care Respir , Allergy Organization , Adolescents With Severe , Uncontrolled Asthma ,